Pfizer-BioNTech on February 17 announced that the nCoV variant from South Africa could reduce two-thirds of the antibody in its Covid-19 vaccine. Laboratory studies show that vaccines can still neutralize the virus, but there is no evidence from clinical trials that the new variant reduces the effectiveness of the vaccine. The pharmaceutical company is discussing […]
